Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Carcinoma, Renal Cell × Radiotherapy × Clear all

Phase

Phase 2 5 Phase 1/2 3 Phase 1 3 Phase NA 1 Phase 4 1 Phase 3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Carcinoma, Non-Small-Cell Lung 3 Breast Neoplasms 2 Anemia 2 Waldenstrom Macroglobulinemia 1 Uterine Cervical Neoplasms 1 Recurrence 1 Rectal Neoplasms 1 Prostatic Neoplasms 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Oropharyngeal Neoplasms 1 Neoplasms, Plasma Cell 1 Neoplasms 1 Myelodysplastic Syndromes 1 Multiple Myeloma 1 Mouth Neoplasms 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Mantle-Cell 1 Lymphoma, Large-Cell, Immunoblastic 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma, Follicular 1 Lymphoma, B-Cell, Marginal Zone 1 Lymphoma 1 Lung Neoplasms 1 Leukemia, Promyelocytic, Acute 1 Leukemia, Myelomonocytic, Acute 1 Leukemia, Myeloid, Chronic-Phase 1 Leukemia, Myeloid, Acute 1 Leukemia, Myeloid, Accelerated Phase 1 Leukemia, Megakaryoblastic, Acute 1 Leukemia, Lymphocytic, Chronic, B-Cell 1

Interventions

Sunitinib 5 Everolimus 5 Nivolumab 4 pazopanib 3 cabozantinib 2 aldesleukin 2 palbociclib 1 olaparib 1 lenvatinib 1 Zoledronic Acid 1 Tobacco Use Cessation Devices 1 Standard of Care 1 Sorafenib 1 Single Person 1 Radiotherapy 1 Psychiatric Rehabilitation 1 Polymerase Chain Reaction 1 Nutrition Therapy 1 Midazolam 1 Ipilimumab 1 Interferons 1 High-Energy Shock Waves 1 Gene Expression Profiling 1 Gemcitabine 1 Erlotinib Hydrochloride 1 Early Intervention, Educational 1 Counseling 1 Caffeine 1 Bupropion 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06903312 2025-07-03

ITALIC-RCC

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Phase 4 Recruiting

Carcinoma, Renal Cell, Kidney Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡